Polymorphism in coronary artery vasoconstriction
Author(s) -
K Schwartz
Publication year - 2001
Publication title -
european heart journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.336
H-Index - 293
eISSN - 1522-9645
pISSN - 0195-668X
DOI - 10.1053/euhj.2000.2530
Subject(s) - medicine , cardiology , vasoconstriction , artery
This, however, should not discourage the cardiologist. Simply measuring diastolic thickening should at least provide an idea of which patients need further sophisticated testing; (5) finally and, perhaps most importantly, the study stressed the importance of the fact that the extent of viability is related to better survival — the bigger the area of hibernation, the better the survival. This point is clinically critical, as a small area of viable myocardium was related to a higher incidence of cell death. Therefore, the cardiologist should aim to reperfuse only when there is enough hibernating myocardium able to recover. I have only one concern regarding the study and this relates to its acronym ‘VIDA’ (Viability Identification with Dipyridamole Administration). I am, as are the main authors, Italian and, in Italian, ‘vita’ means ‘life: perhaps a ‘t’ instead of a ‘d’ would have been more appropriate! R. FERRARI University of Ferrara, Italy References
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom